Mohan Reddy Of SkyHive On The Future Of Artificial Intelligence

An Interview With Ben Ari

Biotechnology companies are applying AI and machine learning to drug development processes, potentially creating dozens of new medicines and a multi-billion dollar market over the next decade while reducing cost-inefficient guesswork.

As part of our series about the future of Artificial Intelligence, I had the pleasure of interviewing Mohan Reddy.

Mohan Reddy is the CTO of SkyHive and oversees all aspects of developing and delivering SkyHive’s technology capabilities, including machine learning and deep learning systems. He is also Associate Director at Stanford University’s Human Perception Lab. Specializing in building scalable systems, robotics, and computational neuroscience, Mohan has worked at multiple companies, including Zynga, IBM, Schlumberger and Expedia.

Thank you so much for joining us in this interview series! Can you share with us the ‘backstory” of how you decided to pursue this career path in AI?

I attained a bachelor’s degree in Biomedical Engineering, a master’s in Electrical Engineering, and an MBA with a specialization…